Skip to content
Excelsior
About Excelsior Medical
Enterprise Spirit
Development Strategy
Related Company
Overseas Business
Company History
Product Description
Hemodialysis / Plasma Exchange
Blood Bag
Artificial Stoma
Health Appliances
ESG
Investors
Enterprise Recruitment
Contact Us
繁體中文
Investors
Investor Zone
Material Information
Board of Directors
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders’ Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investor
Material Information
Announcement the Company’s Board of directors authorizes the chairman to set the ex-rights and capital increase record date.
2025-08-12
The Board of Directors approved Q2 2025 consolidated financial statements.
2025-08-12
Announcement of the Board of Directors on election of Chairperson on behalf of major subsidiary, Excelsior Asset Management Co., Ltd.
2025-08-08
Announcement of change in representative of institutional director and supervisor on behalf of major subsidiary,Excelsior Asset Management Co., Ltd.
2025-08-07
Announcement for the expected date of the Board meeting for the Second Quarter of 2025 Financial Report is 2025/08/12
2025-08-04
Announcement the Company’s Board of Directors resolved to appoint the Remuneration Committee members.
2025-07-25
Announcement about renewal of the Company’s Chairman and Vice Chairman
2025-06-26
Announcement of members of the Company’s 4th Audit Committee
2025-06-26
The 2025 Annual Shareholders’ Meeting passes to release the prohibition on directors from participation in competition businesses.
2025-06-26
The 2025 Annual Shareholders’ Meeting approved the Company’s list of newly elected directors (including independent directors).
2025-06-26
